See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2023_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 344,261,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 279,856,000 |
| 2 | PropertyPlantAndEquipmentNet | 43,246,000 |
| 3 | remainder_Assets | 92,724,000 |
| 4 | LiabilitiesCurrent | 99,439,000 |
| 5 | LiabilitiesNoncurrent | 287,050,000 |
| 6 | remainder_Liabilities | 35,058,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 322,626,930 |
| 9 | ResearchAndDevelopmentExpense | 20,072,081 |
| 10 | remainder_Expenses | 231,476,495 |
| 11 | remainder_Revenues | 706,620,746 |
| 12 | remainder_NetIncome | -30,111,919 |
| 13 | remainder_ComprehensiveNetIncome | 18,613,685 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 760,087,000 |
| 1 | Liabilities | 421,547,000 |
| 2 | Expenses | 574,175,506 |
| 3 | Revenues | 706,620,746 |
| 4 | StockholdersEquity | 338,540,000 |
| 5 | NetIncome | 102,333,321 |
| 6 | ComprehensiveNetIncome | 111,640,164 |
| 7 | BaseVar | 1,255,577,928 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.44 |
| 9 | EconomicCapitalRatio | 2.63 |
Edgar->Model Mapping
Feature Distribution
Change over Time
